8.2.2024
•
News
M&A
Tax
Assisting the owners in the sale of ANESAN
KSB's team led by Drahomír Tomašuk and Ján Béreš, with the support of Jan Černohouz, provided the owners of ANESAN with comprehensive legal advice on the sale of 100% of the company. ANESAN operates a long-term acute care hospital in Český Brod, which is the oldest healthcare facility of its kind in the Czech Republic. ANESAN’s facility is located on the premises of the Český Brod hospital and has a total capacity of 15 beds and a highly specialized team of doctors and nurses. The buyer is the Penta Hospitals CZ group.
In addition to preparing the company for sale, providing due diligence on the sellers' side, and preparing and negotiating the transaction documentation, our services included corporate and tax advisory.
More information can be found here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
